A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody

PURPOSE: To review pharmacokinetic and pharmacodynamic characteristics of antibodies that bind to soluble ligands within the framework of calcitonin gene-related peptide antibodies. OVERVIEW: Calcitonin gene-related peptide has been implicated in the pathophysiology of migraine. Galcanezumab is an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kielbasa, William, Helton, Danielle L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710614/
https://www.ncbi.nlm.nih.gov/pubmed/30917684
http://dx.doi.org/10.1177/0333102419840780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710614/
https://www.ncbi.nlm.nih.gov/pubmed/30917684
http://dx.doi.org/10.1177/0333102419840780

Ejemplares similares